H.R. 586House bill · 119th CongressIn the SenateArmed Forces and National Security

Vietnam Veterans Liver Fluke Cancer Study Act

Sponsored byNick LaLotaR-NY-1Introduced Jan 21, 2025Full text on congress.gov ↗

Latest action (Apr 8, 2025) Received in the Senate and Read twice and on Veterans' Affairs.

What it does

Congressional Research Service, Jan 21, 2025

This bill requires the Department of Veterans Affairs (VA) to conduct an epidemiological study and report on the prevalence of cholangiocarcinoma (bile duct cancer) in veterans who served in the Vietnam theater of operations during the Vietnam era. The study must identify the rate of incidence of cholangiocarcinoma in such veterans and in U.S. residents.

The bill also requires the VA to track and report on the prevalence of cholangiocarcinoma using the Veterans Affairs Central Cancer Registry. Additionally, the VA must periodically submit follow-up reports to Congress regarding the epidemiological study and information collected from the cancer registry regarding the prevalence of bile duct cancer.

Face Value

as passed the House
100Narrow

How much of this bill its name accounts for.

  • Every bill starts at100
  • Nothing counted against it: one area of law, and short enough that length doesn't register.

Face Value measures reach, not honesty. A big bill can be accurately named, and a low score is not an accusation — it means the contents reach further than any short title could describe. Count it yourself ↗ How this is worked out

What Congress did

1 recorded
  • On , as Amendeddecisive vote

    House · Apr 7, 2025

    A fast-track vote: no amendments, short debate, and two thirds needed to pass. Used for bills expected to be uncontroversial.

    4110

    Passed

    Every vote →

Discussion

0 comments

Sign in to join the discussion and put your vote on the record.

Sort

No comments yet. Be the first to make the case.

Your position on H.R. 586No positions yet